1Xiao Wei Li~1 Yan Qing Ding~1 Jun Jie Cai~1 Shao Qing Yang~2 Lian Bing An~3 Dong Fang Qiao~3 ~1Department of Pathology,Nanfang Hospital of the First Military Medical University,Guangzhou 510515,Guangdong Province,China ~2The Northern Hospital of PLA,Shenyang 110015,Liaoning Province,China ~3Department of Electronmicroscopy,First Military Medical University,Guangzhou 510515,Gangdong Province,ChinaDr.Xiao Wei Li graduated from the First Military Medical University with a MM degree in 1999.Physician in Charge of pathology,having 6 papers published..Studies on mechanism of Sialy Lewis-X antigen in liver metastases of human colorectal carcinoma[J].World Journal of Gastroenterology,2001,7(3):425-430. 被引量：19
3[7]McIntire KR,Waldmann TA,Moertel CG,Go VL,Serum alphafetoprotein in patients with neoplasms of the gastrointestinal tract.Cancer Res 1975; 35:991-996
4[8]Gallo V,Cerutti E,Riberi A,Re M,Petrino R,Pecchio F.Alphafetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.J Nucl Med Allied Sci 1989; 33:89-93
5[9]Alpert E,Feller ER.Alpha-fetoprotein (AFP) in benign liver disease.Evidence that normal liver regeneration does not induce AFP synthesis.Gastroenterology 1978; 74:856-858
6[10]Nguyen MH,Garcia RT,Simpson PW,Wright TL,Keeffe EB.Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.Hepatology 2002; 36:410-417
8[12]Stahel RA,Gilks WR,Lehmann HP,Schenker T.Third International Workshop on Lung Tumor and Differentiation Antigens:overview of the results of the central data analysis.Int J Cancer Suppl 1994; 8:6-26
6Takahashi I, Takahashi T, Tsuchida S. Pulse methyprednisolone therapy in type 3 adenovirus pneumonia with hypercytokinemia[J]. Tohoku J Exp Meal,2006,209(1): 69-73.
8Yokoyama A, Kohno N, Hamada H, et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Meal, 1998,158(5):1680- 1684.
9Ohnishi H, Yokoyama A, Kohno K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein D, and monoeyte chemoattractant protein-1 as serum makers for interstitial lung diseases[J]. Am J Respir Crit Care Med, 2002, 165(3) :378-381.
10Shyamsundar M, McAuley D. KL-6 in acute lung injury: will it leave itsmark[J]. Crit Care, 2008,12(2):121.
